Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.11.23 | AFT Pharmaceuticals - Global growth despite tough macro environment | 270 | Edison Investment Research | AFT Pharmaceuticals reported solid H124 top-line growth, driven by strong momentum in the Asian and international markets. H124 revenues of NZ$83.6m grew 27.2% from H123, bolstered by 171.4% and 47.8%... ► Artikel lesen | |
27.11.23 | OSE Immunotherapeutics - Collaboration bolsters upcoming Tedopi Phase III | 311 | Edison Investment Research | OSE Immunotherapeutics (OSE) has announced a collaboration with GenDx for the development and validation of a companion diagnostic screening test to support its upcoming Phase III trial for Tedopi,... ► Artikel lesen | |
27.11.23 | ReNeuron Group - H124 results reaffirm focus on CustomEx | 370 | Edison Investment Research | ReNeuron has announced its H124 results (to end-September 2023), reaffirming its commitment to advance CustomEx , its proprietary stem cell-derived exosome delivery platform. The key operational update... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 323 |
BAYER | 247 |
BYD | 166 |
NEL | 165 |
DEUTSCHE BANK | 162 |
TUI | 153 |
TESLA | 140 |
NVIDIA | 139 |
RWE | 131 |
RHEINMETALL | 130 |
PLUG POWER | 127 |
MERCEDES-BENZ | 121 |
APPLE | 117 |
DEUTSCHE LUFTHANSA | 112 |
SUPER MICRO COMPUTER | 110 |
BERKSHIRE HATHAWAY | 108 |
PALANTIR TECHNOLOGIES | 101 |
XIAOMI | 94 |
AMAZON | 91 |
VOLKSWAGEN | 91 |
AIXTRON SE | 89 |
BASF | 82 |
COMMERZBANK | 80 |
RENK GROUP | 80 |
SIEMENS ENERGY | 76 |